Breaking Down Zhejiang Xinan Chemical Industrial Group Co.,Ltd Financial Health: Key Insights for Investors

Zhejiang Xinan Chemical Industrial Group's financial picture is a study in contrasts: FY2024 revenue edged up to CNY 14.67 billion while TTM revenue as of June 30, 2025 fell to CNY 14.23 billion, and net income plunged to CNY 51.41 million in 2024 with a TTM net loss of -CNY 9.92 million, even as the company carries total debt of CNY 3.21 billion against CNY 13.64 billion in equity; margins and profitability are strained (gross margin 10.37%, operating margin -0.74%, ROE -0.11%), liquidity shows a current ratio of 1.40 but a quick ratio of 0.79 and negative free cash flow of -CNY 1.16 billion, valuation metrics swing from a lofty TTM P/E of 108.29 to a forward P/E of 17.02 while P/B sits at 0.90, and investors must weigh regulatory and raw-material risks alongside growth catalysts such as silicone expansion, new pesticides, digital agriculture initiatives and an MOU with Petronas as they decide whether to dive deeper into Xinan's balance sheet, cash flows and strategic prospects-read on for the detailed breakdown

Zhejiang Xinan Chemical Industrial Group Co.,Ltd (600596.SS) - Revenue Analysis

Zhejiang Xinan Chemical Industrial Group Co.,Ltd reported modest top-line movement through 2024-H1 2025, with mixed performance across core segments and a declining TTM trend by mid-2025.

• Fiscal year 2024 revenue: CNY 14.67 billion (up 0.24% vs. 2023).
• TTM revenue as of 30 Jun 2025: CNY 14.23 billion (down 2.79% YoY).
• H1 2025 revenue: CNY 7.82 billion (vs. CNY 8.20 billion in H1 2024).
• Workforce: 8,499 employees; revenue per employee ≈ CNY 1.67 million.

Segment-level revenue pressure in 2023 materially affected recent comparatives:

• Agrochemical self-produced products (2023): CNY 4.58 billion, down 38.40% YoY.
• Silicon-based materials basic products (2023): CNY 2.21 billion, down 39.85% YoY.

For deeper stakeholder breakdown and investor activity, see: Exploring Zhejiang Xinan Chemical Industrial Group Co.,Ltd Investor Profile: Who's Buying and Why?

Zhejiang Xinan Chemical Industrial Group Co.,Ltd (600596.SS) - Profitability Metrics

• Primary drivers: compression in gross margin (10.37%) and negative operating margin (-0.74%) reducing operating leverage.
• Capital/earnings impact: diluted EPS of CNY -0.01 and ROE at -0.11% reflect limited returns to equity holders.
• Recent trajectory: FY2024 net income CNY 51.41m (down 61.67% YoY) vs. TTM loss of CNY -9.92m as of 2025-06-30 signals deterioration into 2025.

• Implications for investors: earnings volatility and slim margins increase sensitivity to raw-material cost swings, pricing pressure, and demand cycles.
• Key monitoring points: margin recovery, cost control, and any signs of sustained positive TTM net income.

Zhejiang Xinan Chemical Industrial Group Co.,Ltd (600596.SS) - Debt vs. Equity Structure

• Total debt: CNY 3.21 billion (as of 2025-07-01)
• Total equity (book value): CNY 13.64 billion
• Book value per share: CNY 9.24
• Net cash position: CNY -1.26 billion (net debt)
• Debt-to-equity ratio: 25.91%
• Working capital: CNY 2.37 billion
• Interest coverage ratio: -1.51
• EV/EBITDA: 21.69

• Implication: despite a solid equity base (CNY 13.64B), the negative interest coverage and net debt indicate earnings stress and interest vulnerability.
• Valuation note: EV/EBITDA of 21.69 implies market/enterprise valuation is high relative to operating cash earnings.
• Liquidity: working capital of CNY 2.37B provides operational buffer, but negative net cash and interest coverage remain key risk indicators.

Zhejiang Xinan Chemical Industrial Group Co.,Ltd (600596.SS) - Liquidity and Solvency

Zhejiang Xinan Chemical shows a mixed liquidity and solvency profile: sufficient current assets to cover near-term liabilities but constrained immediate liquidity, a net debt position per share, positive operating cash generation offset by large capital outlays, and a moderate Altman Z-Score indicating elevated financial distress risk relative to highly solvent peers.

• Current ratio: 1.40 - adequate short-term coverage of liabilities.
• Quick ratio: 0.79 - indicates reliance on inventory to meet short-term obligations.
• Operating cash flow: CNY 454.99 million - positive cash generation from core operations.
• Free cash flow: -CNY 1.16 billion - negative after capital expenditures; cash drained by investments/maintenance.
• Net cash per share: -CNY 0.93 - company is effectively net‑debt on a per‑share basis.
• Altman Z-Score: 2.06 - moderate bankruptcy risk zone (below safe threshold ~3.0).

Practical implications for investors:

• Positive operating cash flow supports ongoing operations, but negative FCF signals capital outflows that may require external financing or reduce cash buffers.
• The quick ratio under 1.0 suggests limited immediate liquidity without inventory liquidation; monitor inventory turnover closely.
• Net cash per share being negative means shareholders are exposed to the company's leverage - track debt maturities and refinancing terms.
• Altman Z-Score of 2.06 warrants monitoring of profitability and balance-sheet repairs to avoid downward credit pressure.

For broader investor context and ownership/activity trends, see: Exploring Zhejiang Xinan Chemical Industrial Group Co.,Ltd Investor Profile: Who's Buying and Why?

Zhejiang Xinan Chemical Industrial Group Co.,Ltd (600596.SS) - Valuation Analysis

• TTM P/E: 108.29 - indicates market prices are currently high relative to the last twelve months' reported earnings.
• Forward P/E: 17.02 - implies analysts expect materially higher future earnings or reduced risk, bringing the forward valuation into a more conventional range.
• P/S: 0.79 - the stock trades below one times annual sales, signaling potential revenue-based undervaluation.
• P/B: 0.90 - trading slightly under book value, which can appeal to value-oriented investors assessing balance-sheet protection.
• EV/Revenue: 1.00 - enterprise value equals annual revenue, a straightforward revenue-based valuation benchmark.
• EV/EBITDA: 21.69 - relatively high, indicating the company is valued richly relative to operating cash-flow proxies.

Zhejiang Xinan Chemical Industrial Group Co.,Ltd (600596.SS) - Risk Factors

• Regulatory / Environmental Risk: tighter Chinese environmental standards, periodic regional inspections and mandated production curbs can increase compliance costs and force temporary shutdowns. In recent enforcement cycles (2020-2023) many Chinese chemical producers experienced planned downtime and retrofit CAPEX.
• Competitive Pressure: intense competition from large domestic peers and global agrochemical/specialty-chemical groups may compress pricing and erode market share in both domestic and export markets.
• Cyclicality of End‑Markets: exposure to agricultural crop cycles and construction/industrial demand creates revenue and earnings volatility across quarters and seasons.
• Input Concentration Risk: dependence on key raw materials (notably yellow phosphorus, methanol and phosphorus intermediates) creates price and supply‑security exposure; sharp commodity moves can swing gross margins quickly.
• Operational Disruption Risk: past instances across the industry of production curtailments due to environmental inspections, energy rationing or logistics bottlenecks highlight the business's sensitivity to upstream and local policy actions.
• Trade & Geopolitical Risk: export restrictions, tariffs or non‑tariff barriers in major markets (e.g., U.S., EU, Southeast Asia) could materially reduce addressable export volumes and realizations.

• Examples of realized impacts: when regional environmental inspections force output curtailment, sales volumes can decline 10-25% in affected months; feedstock price spikes (e.g., methanol up >30% year‑on‑year) have historically reduced operating margins by several percentage points.
• Mitigants and considerations for investors: management's procurement strategy (long‑term contracts, hedging), capex allocation toward cleaner production, geographic diversification of sales and inventories, and balance‑sheet flexibility to withstand cyclical downturns.

Zhejiang Xinan Chemical Industrial Group Co.,Ltd (600596.SS) - Growth Opportunities

• Silicones portfolio expansion: Xinan is shifting product mix toward high-value specialty silicones (medical‑grade, electronics, EV components), which typically enjoy higher gross margins than commodity intermediates.
• Agrochemical pipeline and digital agriculture: investing in new pesticide varieties and digital crop‑management solutions can increase lifetime value per customer and capture higher-margin service revenue streams.
• Global market demand tailwinds: secular growth in food demand and renewable energy adoption supports sustained demand for agrochemicals and silicones, respectively.
• Strategic industrial partnerships: agreements such as the MOU with Petronas for silicone production can accelerate technology transfer, scale and access to overseas markets.
• Policy tailwinds: China's push for greener production and consolidation favors larger integrated players with capital to invest in cleaner processes and compliance.

• Global silicone market size: roughly mid‑single digit CAGR (≈4-6% p.a.) over the 2024-2030 period, driven by electronics, renewables and automotive electrification (EVs).
• Global agrochemicals: steady demand underpinned by rising food consumption; mature markets growing low‑single digits while emerging markets expand faster.
• End‑market exposure: silicones can command gross margins several percentage points higher than basic chemical intermediates; capture of specialty product sales is a primary lever for margin expansion.
• Strategic partnerships: MOUs and JV frameworks (e.g., with Petronas) typically reduce time‑to‑market and lower capex per unit of capacity expansion through shared investments or offtake arrangements.

• Revenue mix: % of revenue from specialty silicones vs commodity chemicals (target: rising share of specialties).
• Gross margin and EBITDA margin trends: improvement would signal successful migration to higher‑value products.
• R&D and capex cadence: spend on new pesticide varieties and silicone capacity expansions; product approvals and commercialization timelines.
• Export share and geographic revenue breakdown: evidence of overseas market penetration.
• Partnership milestones: concrete deliverables under MOUs (capacity, timelines, technology transfer metrics).